Literature DB >> 18435928

Crystal structure of the Ca(2+)-form and Ca(2+)-binding kinetics of metastasis-associated protein, S100A4.

Alexandre R Gingras1, Jaswir Basran, Andrew Prescott, Marina Kriajevska, Clive R Bagshaw, Igor L Barsukov.   

Abstract

S100A4 takes part in control of tumour cell migration and contributes to metastatic spread in in vivo models. In the active dimeric Ca(2+)-bound state it interacts with multiple intracellular targets. Conversely, oligomeric forms of S100A4 are linked with the extracellular function of this protein. We report the 1.5A X-ray crystal structure of Ca(2+)-bound S100A4 and use it to identify the residues involved in target recognition and to derive a model of the oligomeric state. We applied stopped-flow analysis of tyrosine fluorescence to derive kinetics of S100A4 activation by Ca(2+) (k(on)=3.5 microM(-1)s(-1), k(off)=20s(-1)).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18435928     DOI: 10.1016/j.febslet.2008.04.017

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism.

Authors:  Bence Kiss; Annette Duelli; László Radnai; Katalin A Kékesi; Gergely Katona; László Nyitray
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-28       Impact factor: 11.205

Review 2.  The heavy chain has its day: regulation of myosin-II assembly.

Authors:  Natalya G Dulyaninova; Anne R Bresnick
Journal:  Bioarchitecture       Date:  2013 Jul-Aug

3.  Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion.

Authors:  Reniqua P House; Maria Pozzuto; Purvi Patel; Natalya G Dulyaninova; Zhong-Hua Li; Wendy D Zencheck; Michele I Vitolo; David J Weber; Anne R Bresnick
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

4.  Solving the crystal structure of human calcium-free S100Z: the siege and conquer of one of the last S100 family strongholds.

Authors:  V Calderone; M Fragai; G Gallo; C Luchinat
Journal:  J Biol Inorg Chem       Date:  2017-01-10       Impact factor: 3.358

5.  Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA.

Authors:  Natalya G Dulyaninova; Karen M Hite; Wendy D Zencheck; Dominic A Scudiero; Steven C Almo; Robert H Shoemaker; Anne R Bresnick
Journal:  Biochemistry       Date:  2011-07-21       Impact factor: 3.162

6.  Phenothiazines inhibit S100A4 function by inducing protein oligomerization.

Authors:  Vladimir N Malashkevich; Natalya G Dulyaninova; Udupi A Ramagopal; Melissa A Liriano; Kristen M Varney; David Knight; Michael Brenowitz; David J Weber; Steven C Almo; Anne R Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

7.  Solution structure and dynamics of S100A5 in the apo and Ca2+-bound states.

Authors:  Ivano Bertini; Soumyasri Das Gupta; Xiaoyu Hu; Tilemachos Karavelas; Claudio Luchinat; Giacomo Parigi; Jing Yuan
Journal:  J Biol Inorg Chem       Date:  2009-06-18       Impact factor: 3.358

8.  Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization.

Authors:  Lucas N Wafer; Franco O Tzul; Pranav P Pandharipande; George I Makhatadze
Journal:  Biochemistry       Date:  2013-08-15       Impact factor: 3.162

9.  Mechanism of the Ca²+-dependent interaction between S100A4 and tail fragments of nonmuscle myosin heavy chain IIA.

Authors:  Sandip K Badyal; Jaswir Basran; Nina Bhanji; Ju Hwan Kim; Alap P Chavda; Hyun Suk Jung; Roger Craig; Paul R Elliott; Andrew F Irvine; Igor L Barsukov; Marina Kriajevska; Clive R Bagshaw
Journal:  J Mol Biol       Date:  2010-11-24       Impact factor: 5.469

10.  Asymmetric mode of Ca²⁺-S100A4 interaction with nonmuscle myosin IIA generates nanomolar affinity required for filament remodeling.

Authors:  Paul R Elliott; Andrew F Irvine; Hyun Suk Jung; Kaeko Tozawa; Martyna W Pastok; Remigio Picone; Sandip K Badyal; Jaswir Basran; Philip S Rudland; Roger Barraclough; Lu-Yun Lian; Clive R Bagshaw; Marina Kriajevska; Igor L Barsukov
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.